title: Swim stress differentially blocks CRF receptor mediated responses in dorsal raphe nucleus.
abstract: Modulation of the serotonergic (5-HT) neurotransmitter system arising from the dorsal raphe nucleus (DR) is thought to support the behavioral effects of swim stress, i.e., immobility. In vivo pharmacological and anatomical studies suggest that corticotropin-releasing factor (CRF) and γ-aminobutyric acid (GABA) synaptic transmission closely interact to set the response of the DR to swim stress. To investigate the cellular basis of these physiological mechanisms the effects of ovine CRF (oCRF) on GABA(A)-dependent miniature inhibitory postsynaptic currents (mIPSCs) in 5-HT and non-5-HT DR neurons in acute mesencephalic slices obtained from rats either naïve or 24h after a 15 min swim stress session were tested. In this study, the effect of swim stress alone was to decrease the holding current, i.e., hyperpolarize the neuron, and to increase the amplitude and charge of mIPSCs recorded from non-5-HT neurons. Ovine CRF (10 nM) induced an increase in mIPSC frequency in 5-HT neurons recorded from naïve rats, an effect that was suppressed by swim stress. The inward current elicited by oCRF in both 5-HT and non-5-HT neurons was also blocked by swim stress. Ovine CRF increased mIPSCs amplitude and charge in both 5-HT and non-5-HT neurons, but this effect was not modified by swim stress. In concert with our previous findings that swim stress decreased input resistance, action potential threshold and action potential duration and increased glutamatergic synaptic activity the overall primary effect of swim stress is to increase the excitability of 5-HT neurons. These data provide a mechanism at the cellular level for the immobility induced by swim stress and identifies critical components of the raphe circuitry responsible for the altered output of 5-HT neurons induced by swim stress.
authors.affiliation: Anesthesiology and Division of Stress Neurobiology, Children's Hospital of Philadelphia Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. christophe.lamy@unil.ch
authors.forename: Christophe M
authors.initials: CM
authors.lastname: Lamy
authors.forename: Sheryl G
authors.initials: SG
authors.lastname: Beck
mesh_terms: D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism / Q000494:pharmacology; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D010805:Physical Conditioning, Animal / Q000009:adverse effects / Q000379:methods; D011897:Random Allocation; D011903:Raphe Nuclei / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D012701:Serotonin / Q000378:metabolism; D012756:Sheep; D013312:Stress, Physiological / Q000502:physiology*; D013550:Swimming / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
chemical_list: D018019:Receptors, Corticotropin-Releasing Hormone; D012701:Serotonin; D003346:Corticotropin-Releasing Hormone
references.citation: J Comp Neurol. 2004 Jun 28;474(3):364-78
references.pmid: 15174080
references.citation: Brain Res. 2003 Jan 24;961(1):109-20
references.pmid: 12535783
references.citation: J Neurosci. 2008 Nov 26;28(48):12927-37
references.pmid: 19036986
references.citation: J Neurosci. 1992 Oct;12(10):4037-44
references.pmid: 1357117
references.citation: Trends Neurosci. 2004 Sep;27(9):569-75
references.pmid: 15331240
references.citation: Eur J Neurosci. 2006 Dec;24(12):3415-30
references.pmid: 17229091
references.citation: Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36
references.pmid: 596982
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12213-8
references.pmid: 14530409
references.citation: Biol Psychiatry. 2009 Jul 1;66(1):76-83
references.pmid: 19362706
references.citation: Behav Neurosci. 1993 Apr;107(2):377-88
references.pmid: 8484901
references.citation: J Psychopharmacol. 2000 Jun;14(2):100-13
references.pmid: 10890306
references.citation: Psychoneuroendocrinology. 2007 Jul;32(6):712-23
references.pmid: 17602840
references.citation: Front Neuroendocrinol. 2003 Jul;24(3):151-80
references.pmid: 14596810
references.citation: J Comp Neurol. 1978 Jun 1;179(3):641-67
references.pmid: 565370
references.citation: J Neuroendocrinol. 2002 Nov;14(11):911-23
references.pmid: 12421345
references.citation: J Comp Neurol. 1991 Dec 15;314(3):558-86
references.pmid: 1814975
references.citation: J Comp Neurol. 1992 Apr 1;318(1):18-26
references.pmid: 1583154
references.citation: Endocrinology. 2008 Jan;149(1):122-30
references.pmid: 17947354
references.citation: J Neurosci. 2008 Aug 13;28(33):8169-77
references.pmid: 18701679
references.citation: Neuroscience. 2001;106(4):783-92
references.pmid: 11682163
references.citation: Neuropsychopharmacology. 1998 Jun;18(6):492-502
references.pmid: 9571657
references.citation: J Neurophysiol. 1999 Oct;82(4):1793-807
references.pmid: 10515969
references.citation: J Neurosci. 2000 Oct 15;20(20):7728-36
references.pmid: 11027235
references.citation: Psychopharmacology (Berl). 2007 Oct;194(3):297-307
references.pmid: 17581742
references.citation: Brain Res. 2006 Jan 27;1070(1):77-89
references.pmid: 16403469
references.citation: Eur J Neurosci. 2004 Sep;20(6):1665-73
references.pmid: 15355334
references.citation: J Neurosci. 2007 May 30;27(22):6045-53
references.pmid: 17537976
references.citation: J Neurosci Methods. 1980 Dec;3(2):129-49
references.pmid: 6110810
references.citation: J Neurosci. 2001 Dec 15;21(24):9917-29
references.pmid: 11739599
references.citation: J Comp Neurol. 2005 Feb 7;482(2):155-65
references.pmid: 15611993
references.citation: Stress. 2005 Dec;8(4):233-46
references.pmid: 16423712
references.citation: J Neurophysiol. 2004 Feb;91(2):994-1005
references.pmid: 14573555
references.citation: J Comp Neurol. 2001 Jul 9;435(4):450-63
references.pmid: 11406825
references.citation: Stress. 1998 Dec;2(4):251-63
references.pmid: 9876256
references.citation: Psychopharmacology (Berl). 2002 Aug;162(4):406-14
references.pmid: 12172694
references.citation: Nature. 1977 Apr 21;266(5604):730-2
references.pmid: 559941
references.citation: J Neurosci. 2000 Jun 1;20(11):4217-25
references.pmid: 10818157
references.citation: J Neurosci. 1995 Oct;15(10):6340-50
references.pmid: 7472399
references.citation: Physiol Rev. 1992 Jan;72(1):165-229
references.pmid: 1731370
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: J Neurosci. 2003 Feb 1;23(3):970-7
references.pmid: 12574426
references.citation: Neuropsychopharmacology. 1997 Nov;17(5):326-41
references.pmid: 9348548
references.citation: Mol Psychiatry. 2003 Mar;8(3):324-32
references.pmid: 12660805
references.citation: J Comp Neurol. 2000 Dec 11;428(2):191-212
references.pmid: 11064361
references.citation: J Neurosci. 2001 Apr 15;21(8):2833-41
references.pmid: 11306635
references.citation: J Neurosci. 2004 Feb 11;24(6):1305-11
references.pmid: 14960601
references.citation: Brain Res. 2005 May 24;1044(2):176-89
references.pmid: 15885216
references.citation: Neuropsychopharmacology. 2000 Feb;22(2):148-62
references.pmid: 10649828
references.citation: Nat Rev Drug Discov. 2005 Sep;4(9):775-90
references.pmid: 16138108
references.citation: Eur Psychiatry. 2005 Oct;20 Suppl 3:S302-6
references.pmid: 16459240
references.citation: Brain Res. 1997 May 2;755(2):229-45
references.pmid: 9175891
references.citation: Brain Res. 2000 Aug 4;873(1):34-45
references.pmid: 10915808
references.citation: Ciba Found Symp. 1993;172:296-308; discussion 308-16
references.pmid: 8491091